Cargando…
PPP1R14B Is a Prognostic and Immunological Biomarker in Pan-Cancer
Recent studies have shown that PPP1R14B was highly expressed in tumor tissues and patients with high expression of PPP1R14B had poor survival rates. However, the function and mechanisms of PPP1R14B in tumor progression remain ill defined. There was also lack of pan-cancer evidence for the relationsh...
Autores principales: | Deng, Mingxia, Peng, Long, Li, Jiamin, Liu, Xiong, Xia, Xichun, Li, Guangqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631915/ https://www.ncbi.nlm.nih.gov/pubmed/34858479 http://dx.doi.org/10.3389/fgene.2021.763561 |
Ejemplares similares
-
Prognostic and Immunological Role of PPP1R14A as a Pan-Cancer Analysis Candidate
por: Wang, Zhaotao, et al.
Publicado: (2022) -
Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker
por: Liu, Kejun, et al.
Publicado: (2022) -
Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role
por: Zhu, Hua, et al.
Publicado: (2021) -
Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker
por: Zhang, Wenqing, et al.
Publicado: (2023) -
Pan-cancer analyses reveal IGSF10 as an immunological and prognostic biomarker
por: Zhou, Yongxia, et al.
Publicado: (2023)